Acevedo-Prado, Antonio
Seoane-Pillado, Teresa
López-Silvarrey-Varela, Angel
Salgado, Francisco-Javier
Cruz, María-Jesus
Faraldo-Garcia, Ana
Nieto-Fontarigo, Juan-Jose
Pértega-Díaz, Sonia
Sanchez-Lastres, J.
San-José-González, Miguel-Angel
Bamonde-Rodríguez, Luis
Garnelo-Suárez, Luciano
Pérez-Castro, Teresa
Sampedro-Campos, Manuel
Gonzalez-Barcala, Francisco-Javier
Funding for this research was provided by:
Fundación María José Jove
Article History
Received: 17 December 2021
Accepted: 5 April 2022
First Online: 16 April 2022
Competing interests
: Gonzalez-Barcala Francisco-Javier has received speaker fees, consulting fees or research grants from ALK, Astra-Zeneca, Bial, Boehringer-Ingelheim, Chiesi, Gebro Pharma, GlaxoSmithKline, Laboratorios Esteve, Menarini, Mundipharma, Novartis, Rovi, Roxall, Sanofi, Stallergenes-Greer and Teva.